NCT01764152View on ClinicalTrials.gov

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Adult Hospitalized
Interventions
OTHER

nasopharyngeal sample

The nasopharyngeal sample will be used to find the types and subtypes of influenza virus and other respiratory viruses.

Trial Locations (1)

75654

Institut National de la Santé Et de la Recherche Médicale, Paris

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV